Transaction in Own Shares 09 January, 2025 • • • • • • • • • • • • • • • •         Shell plc (the ‘Company’) announces that on 09 January 2025 it ...

PRESS RELEASE         Ubisoft.com Strategic update Paris, January 9, 2025 – Following the strategic and execution reviews initiated by ...

Reference is made to the stock exchange notices published by Ultimovacs ASA (the "Company") on (i) 17 December 2024 ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Agreement Newron and Myung In Pharm announce license agreement for evenamide in South Korea 09.01.2025 / 07:00 CET/CEST The issuer is solely ...

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA POSTS RECORD SALES OF CHF 11.76 BILLION IN 2024 -- ...

Dovre Group Plc                Inside information                January 8, 2025, at 5.15 pm Dovre's subsidiary Suvic Oy has signed a conditional ...

Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San ...

Published extended data from the phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting MS in the peer reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official ...

GMT/BST   Britvic plc 7 January 2025   DIRECTOR/PDMR ...

Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: ...